MDCXW · Medicus Pharma Ltd. · Documents
$0.24
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“This uncertainty, along with the Company's history of losses, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$3.13M
Shares
1.26M
Volume · Oct 27
674
Avg daily vol (3M)
1291
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Medicus Pharma Ltd. regained Nasdaq compliance with the $1.00 minimum bid price requirement on October 23, 2026, closing the matter after Nasdaq had determined on October 20, 2026 to delist its shares and warrants. | 2026-10-23 | 2026-10-20 | |
| PRE 14A | Medicus Pharma Ltd. will seek shareholder approval on December 2, 2026 to create unlimited Class A blank cheque preferred shares, authorize a reverse share split up to 1 pre-split Common Share for every 50 post-split Common Shares, and approve meeting adjournment. | 2026-10-19 | 2026-12-02 | |
| 8-K | Medicus Pharma Ltd. effected a 1-for-50 share consolidation of its common shares on October 12, 2026, after its board approved the ratio on September 24, 2026; shares began trading on a post-consolidation basis on Nasdaq the same day. | 2026-10-16 | 2026-10-12 | |
| 8-K | Medicus Pharma Ltd. will effect a fifty-to-one common share consolidation effective October 12, 2026 to regain Nasdaq Capital Market minimum bid-price compliance; every 50 common shares will become one, and the ticker will remain MDCX. | 2026-10-07 | — | |
| 8-K | — | 2026-09-14 | 2026-09-11 | |
| 8-K | — | 2026-09-11 | 2026-09-04 | |
| 8-K | — | 2026-09-03 | 2026-09-02 | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-06-04 | 2026-06-03 | |
| 8-K | — | 2026-05-27 | 2026-05-20 | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| ARS | — | 2026-05-04 | 2025-12-31 | |
| DEF 14A | — | 2026-05-04 | 2026-06-03 | |
| 10-K/A | — | 2026-04-29 | 2025-12-31 | |
| 8-K | — | 2026-04-24 | 2026-04-21 | |
| PRE 14A | — | 2026-04-21 | 2026-06-03 | |
| Investor Event Transcript | — | 2026-03-26 | 2026-03-31 | |
| 10-K | — | 2026-03-25 | 2025-12-31 | |
| 8-K | — | 2026-03-06 | 2026-03-05 | |
| S-3 | — | 2026-01-30 | — | |
| S-3 | — | 2025-12-30 | — | |
| 8-K | — | 2025-12-30 | 2025-12-29 | |
| 8-K | — | 2025-12-08 | 2025-12-05 | |
| 8-K | — | 2025-12-01 | 2025-11-28 | |
| S-1 | — | 2025-11-19 | — | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-11-14 | — | |
| 8-K | — | 2025-10-17 | 2025-10-16 | |
| S-1 | — | 2025-09-29 | — | |
| S-1 | — | 2025-09-29 | — | |
| 8-K | — | 2025-09-18 | 2025-09-17 | |
| 8-K | — | 2025-09-12 | — | |
| 8-K | — | 2025-09-02 | 2025-08-29 | |
| 8-K | — | 2025-08-22 | 2025-08-21 | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-08-04 | — | |
| 8-K | — | 2025-07-30 | 2025-07-29 | |
| 8-K | — | 2025-07-23 | 2025-07-22 | |
| 8-K | — | 2025-07-14 | — | |
| 8-K/A | — | 2025-07-03 | 2025-06-29 | |
| ARS | — | 2025-06-30 | 2024-12-31 | |
| 8-K | — | 2025-06-30 | 2025-06-29 | |
| DEF 14A | — | 2025-06-30 | 2025-07-22 | |
| 8-K | — | 2025-06-23 | — | |
| 8-K | — | 2025-06-20 | 2025-06-17 | |
| PRE 14A | — | 2025-06-13 | 2025-07-22 | |
| 8-K | — | 2025-06-05 | 2025-06-03 | |
| 8-K | — | 2025-06-02 | 2025-05-29 | |
| S-1 | — | 2025-05-27 | — | |
| S-1 | — | 2025-05-27 | — |
Showing 1–50 of 75 filings